Immunotherapy has revolutionized the field of oncology by utilizing the body's immune system to fight cancer. This article aims to provide physicians with an in-depth understanding of this groundbreaking treatment modality.
Immunotherapy works by enhancing the immune response against cancer cells. It includes a range of treatment options such as immune checkpoint inhibitors, cancer vaccines, and adoptive cell transfer. These therapies can be used alone or in combination with other treatments to increase their effectiveness.
Immune checkpoint inhibitors are drugs that block immune checkpoints. These checkpoints are proteins that prevent immune cells from attacking normal cells in the body. By blocking these checkpoints, the drugs allow immune cells to respond more strongly to cancer. Key checkpoint inhibitors include PD-1/PD-L1 inhibitors and CTLA-4 inhibitors.
Cancer vaccines, unlike traditional vaccines, are usually given after a cancer diagnosis to stimulate the immune system to attack cancer cells. These vaccines can be specific to a type of cancer or customized to an individual patient's cancer.
Adoptive cell transfer involves modifying a patient's immune cells to enhance their ability to fight cancer. CAR-T cell therapy, a form of adoptive cell transfer, has shown promising results in treating certain types of leukemia and lymphoma.
While immunotherapy has proven effective, it's not suitable for every patient. Physicians must consider factors like the type and stage of cancer, patient health, and previous treatments. Side effects can range from mild to severe and may include fatigue, pain, and immune-related adverse events.
Immunotherapy is a powerful tool in the fight against cancer. As our understanding of the immune system and cancer biology continues to grow, so too will the potential of immunotherapy. It's crucial for physicians to stay updated on this rapidly evolving field to provide the best possible care for their patients.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation